NCT04337177 2025-09-23Flavored, Oral Irinotecan VAL-413 (OrotecanĀ®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid TumorsValent Technologies, LLCPhase 1 Recruiting20 enrolled
NCT06566092 2025-06-29Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult ParticipantsIovance Biotherapeutics, Inc.Phase 1 Recruiting40 enrolled